You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Heart Disease Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 2 of 2 | Results 11 of 11

Transcatheter Aortic Valve Replacement in Low Risk Patients

The purpose of this study is to demonstrate that the safety and effectiveness of the Medtronic Transcatheter Aortic Valve Replacement (TAVR) system as measured by rates of all-cause mortality or disabling stroke at two years is non-inferior to Surgical Aortic Valve Replacement (SAVR) in the treatment of severe aortic stenosis in subjects who have a low predicted risk of operative mortality for SAVR.

Heart

Baystate Medical Center, 759 Chestnut Street, Springfield, MA 01199

Page 2 of 2 | Results 11 of 11